CDKN1B and neoplasm: Taken together, our studies demonstrate that elevating SOX2 in tumor cell lines representing four human tumor types leads to downregulation of a broad spectrum of the cell machinery required for progression through the G1, S, and G2/M phases of the cell cycle, while upregulating or altering the subcellular localization of p27Kip1.